SPY366.02+3.96 1.09%
DIA298.44+1.82 0.61%
IXIC12,355.11+156.37 1.28%

OncoCyte Corporation Common Stock Q3 EPS $(0.10) Misses $(0.09) Estimate, Sales $555.00K Beat $370.00K Estimate

OncoCyte Corporation Common Stock (AMEX:OCX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is unchanged from the same period last year. The

· 11/12/2020 16:12
OncoCyte Corporation Common Stock (AMEX:OCX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is unchanged from the same period last year. The company reported quarterly sales of $555.00 thousand which beat the analyst consensus estimate of $370.00 thousand by 50.00 percent.